InsidersTradesSigma
Follow the Nath Bio-Genes (India) Limited share price and the full management transaction log of the company, a listed issuer based in India. Shares are listed on the IN market, under the authority of SEBI (PIT + SAST). Operating in the Chemicals sector, Nath Bio-Genes (India) Limited has logged 29 public disclosures. Market capitalisation: €3bn. The latest transaction was disclosed on 9 January 2026 (Purchase). Among the most active insiders: AGRI-TECH (INDIA) LTD.. The full history is accessible without an account.
29
Insider Decl.
n/a
Thresholds
€7m
16 ops.
Buy Volume
€5m
13 ops.
Sell Volume
10Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 8,093 of 29,064 companies
62.5
score / 100
Value66
Quality59
FCF yld-5.1%
Earn yld14%
EV/EBITDA6.7x
ROE6.3%
Gross mgn55%
Net mgn9.4%
Debt/EBITDA2.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 9 January 2026
Declarations29 total
75,645 shares@ ₹10.00100.0% of flowEquity SharesSEBI:0f062e810c0fbdef78af074d1515032b3385fba5
75,271 shares@ ₹10.00100.0% of flowEquity SharesSEBI:c9b3d9acbd853af520c74a1efe9b03182a569225
374 shares@ ₹10.00100.0% of flowEquity SharesSEBI:4c04afac164d19a9e1b3245db624bc050eb4f275
168,800 shares@ ₹211.00100.0% of flowEquity SharesSEBI:2fa2b2aea22e92063ba30234c51b6db4dab82de1
168,800 shares@ ₹211.008.0% of flowEquity SharesSEBI:0a590233e55962bd797ab3dd9364183fda1d283f
311,831 shares@ ₹199.2529.3% of flowEquity SharesSEBI:23fae57e3ab8ebef733c67848717f30b0a76317d
311,831 shares@ ₹199.2514.0% of flowEquity SharesSEBI:d2dc93ad6d8ec62ea11bccb9c1e3ffde3ce32fd7
510,500 shares@ ₹196.0022.9% of flowEquity SharesSEBI:3bb7a243f8e57c8bf1db04d05327c1417db46b1c
510,500 shares@ ₹196.00100.0% of flowEquity SharesSEBI:4299d79d00dc258b1b8d9b6db5341f3d262c9337
170,321 shares@ ₹176.93747.7% of flowEquity SharesSEBI:4185539d7ac475fa6690e1af48515d8a2dafe35f
690,000 shares@ ₹180.0568100.0% of flowEquity SharesSEBI:7393226372c26073923ea365ea3cbece7c411769
2,798 shares@ ₹188.60290.1% of flowEquity SharesSEBI:b0b29251c28c6791a3477dde145a4677de6430d7
100,000 shares@ ₹264.006.4% of flowEquity SharesSEBI:2935cf04c7f41303f44ed08ef775acda36a2fd7d
100,000 shares@ ₹264.0050.3% of flowEquity SharesSEBI:ca6110b644473ec1783f58d7b67ae3a47d8dcd91
100,000 shares@ ₹264.006.5% of flowEquity SharesSEBI:2cb2244bbd1e0fe432a5b663c25613794fe1f7d5
100,000 shares@ ₹264.0049.7% of flowEquity SharesSEBI:2ba836a01d55a1c5fa7110c37b57a47cc1a2859f
332,000 shares@ ₹230.970739.4% of flowEquity SharesSEBI:f842c7eb5a33460ba9d83dd84153b2ba92053186
332,000 shares@ ₹230.970755.7% of flowEquity SharesSEBI:fdef43a0c57fd242eef1dbb734c3fc217f24c3ca
290,000 shares@ ₹234.723716.7% of flowEquity SharesSEBI:ec177808d7306020e2b51fe561b9badb8462f1d3
285,526 shares@ ₹253.982117.8% of flowEquity SharesSEBI:33033b6a26d248d41cc635bc31d39931309bf2f7
45,000 shares@ ₹261.508.5% of flowEquity SharesSEBI:378cb9f52d32b7a8268a293f19f55c071216fda0
45,000 shares@ ₹261.506.0% of flowEquity SharesSEBI:bd0f45011de2b30bf980545e6897b1a515b6b47b
25,000 shares@ ₹536.03716.8% of flowEquity SharesSEBI:d30a224d653b8454efb1ab0df4e9b346b9773438
25,000 shares@ ₹536.03719.7% of flowEquity SharesSEBI:dca06b04befbca88ec86efe0445b7d513ab67a57
50,000 shares@ ₹268.01869.8% of flowEquity SharesSEBI:635cf6c2ef03e161a1b85270bde5efc90fc6783b
25 of 29 declarations
关于 Nath Bio-Genes (India) Limited
Nath Bio-Genes (India) Limited 是一家生物技术公司，专注于种子和农业解决方案的开发。它主要在印度市场运营，并专注于作物改良。